HTR1A, which is one of the serotonin receptor polymorphisms (5-HTR1A, 5-HTR2A), is suggested to be involved in the pathogenesis of MDD and the antidepressant treatment response (50–52). The gene discussed is HTR1A; the disease is major depressive disorder.